Over the last 7 days, the Life Sciences industry has risen 1.5%, driven by gains from AddLife of 4.5%. During this same period, the BICO Group underperformed, falling 25%. This means that the industry has gained 4.3% over the past year. Earnings are forecast to grow by 30% annually.
Has the Swedish Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 24 Aug 2025 | SEK 35.4b | SEK 14.7b | SEK 59.9m | 58.8x | 591.4x | 2.4x |
Tue, 22 Jul 2025 | SEK 46.1b | SEK 16.7b | SEK 444.3m | 62.1x | 103.8x | 2.8x |
Thu, 19 Jun 2025 | SEK 46.5b | SEK 16.6b | SEK 405.8m | 71.1x | 114.7x | 2.8x |
Sat, 17 May 2025 | SEK 46.4b | SEK 16.6b | SEK 415.3m | 45x | 111.7x | 2.8x |
Mon, 14 Apr 2025 | SEK 34.9b | SEK 16.6b | SEK 609.4m | 36.9x | 57.3x | 2.1x |
Wed, 12 Mar 2025 | SEK 36.4b | SEK 16.6b | SEK 614.9m | 39.2x | 59.2x | 2.2x |
Fri, 07 Feb 2025 | SEK 44.1b | SEK 17.0b | -SEK 1,038,511,426.00 | 44x | -42.4x | 2.6x |
Sun, 05 Jan 2025 | SEK 43.5b | SEK 16.7b | -SEK 1,152,911,426.00 | 49.2x | -37.8x | 2.6x |
Tue, 03 Dec 2024 | SEK 42.4b | SEK 16.7b | -SEK 1,154,323,426.00 | 49x | -36.7x | 2.5x |
Thu, 31 Oct 2024 | SEK 43.8b | SEK 16.8b | -SEK 956,465,491.00 | 51.1x | -45.8x | 2.6x |
Sat, 28 Sep 2024 | SEK 48.3b | SEK 16.7b | -SEK 988,175,491.00 | 59.2x | -48.9x | 2.9x |
Mon, 26 Aug 2024 | SEK 48.7b | SEK 16.7b | -SEK 986,068,538.00 | 61.2x | -49.4x | 2.9x |
Wed, 24 Jul 2024 | SEK 49.2b | SEK 16.6b | -SEK 1,138,220,510.00 | 59.8x | -43.3x | 3x |
Fri, 21 Jun 2024 | SEK 42.6b | SEK 16.3b | -SEK 1,188,686,510.00 | 55x | -35.9x | 2.6x |
Sun, 19 May 2024 | SEK 42.2b | SEK 16.3b | -SEK 1,188,457,671.00 | 60.7x | -35.5x | 2.6x |
Tue, 16 Apr 2024 | SEK 38.3b | SEK 16.0b | -SEK 1,122,792,213.00 | 35.3x | -34.1x | 2.4x |
Thu, 14 Mar 2024 | SEK 40.4b | SEK 16.0b | -SEK 1,123,139,210.00 | 42x | -35.9x | 2.5x |
Sat, 10 Feb 2024 | SEK 39.7b | SEK 15.8b | -SEK 1,473,823,683.00 | 56.5x | -26.9x | 2.5x |
Mon, 08 Jan 2024 | SEK 35.9b | SEK 15.5b | -SEK 1,393,723,683.00 | 43.5x | -25.8x | 2.3x |
Wed, 06 Dec 2023 | SEK 35.2b | SEK 15.5b | -SEK 1,393,723,683.00 | 42.2x | -25.3x | 2.3x |
Fri, 03 Nov 2023 | SEK 31.0b | SEK 15.4b | -SEK 1,255,923,711.00 | 34.1x | -24.7x | 2x |
Sun, 01 Oct 2023 | SEK 26.8b | SEK 15.1b | -SEK 1,134,516,711.00 | 39.8x | -23.6x | 1.8x |
Tue, 29 Aug 2023 | SEK 30.6b | SEK 15.1b | -SEK 1,138,067,831.00 | 41x | -26.9x | 2x |
Thu, 27 Jul 2023 | SEK 33.0b | SEK 14.9b | -SEK 239,671,038.00 | 47.5x | -137.6x | 2.2x |
Sat, 24 Jun 2023 | SEK 35.7b | SEK 14.6b | -SEK 172,476,038.00 | 38.7x | -207.1x | 2.4x |
Mon, 22 May 2023 | SEK 39.6b | SEK 14.6b | -SEK 175,477,906.00 | 40.1x | -225.6x | 2.7x |
Wed, 19 Apr 2023 | SEK 32.5b | SEK 14.6b | -SEK 57,449,459.00 | 34.1x | -566x | 2.2x |
Fri, 17 Mar 2023 | SEK 34.1b | SEK 14.6b | -SEK 57,185,459.00 | 31.9x | -596.2x | 2.3x |
Sun, 12 Feb 2023 | SEK 40.4b | SEK 14.4b | SEK 827.0m | 37.3x | 48.9x | 2.8x |
Tue, 10 Jan 2023 | SEK 39.7b | SEK 14.2b | SEK 943.9m | 40.5x | 42.1x | 2.8x |
Thu, 08 Dec 2022 | SEK 37.1b | SEK 14.1b | SEK 944.3m | 41.9x | 39.3x | 2.6x |
Sat, 05 Nov 2022 | SEK 33.6b | SEK 13.9b | SEK 761.4m | 48.6x | 44.1x | 2.4x |
Mon, 03 Oct 2022 | SEK 32.9b | SEK 13.5b | SEK 750.9m | 48.3x | 43.8x | 2.4x |
Wed, 31 Aug 2022 | SEK 38.2b | SEK 13.5b | SEK 749.8m | 52.5x | 51x | 2.8x |
51x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | 2.20% | |
Healthcare | 3.45% | |
Life Sciences | 1.48% | |
Clinical Research and Equipment | 1.48% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ALIF B AddLife | SEK 172.60 | 4.5% +SEK 914.0m | 10.9% | PE62.4x | |
MCAP MedCap | SEK 664.00 | 1.7% +SEK 165.5m | 22.3% | PE50.3x | |
MAGLE Magle Chemoswed Holding | SEK 23.00 | 21.1% +SEK 82.1m | -39.8% | PS1.6x | |
GENO Genovis AB (publ.) | SEK 24.00 | 0.4% +SEK 6.6m | -0.4% | PE58.8x | |
LEVBIO Level Bio | SEK 0.39 | 19.6% +SEK 4.4m | 30.4% | PS0.9x |